טוען...
Clinical trial designs for testing biomarker-based personalized therapies
BACKGROUND: Advances in molecular therapeutics in the past decade have opened up new possibilities for treating cancer patients with personalized therapies, using biomarkers to determine which treatments are most likely to benefit them, but there are difficulties and unresolved issues in the develop...
שמור ב:
| הוצא לאור ב: | Clin Trials |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4296980/ https://ncbi.nlm.nih.gov/pubmed/22397801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774512437252 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|